MYR PHARMACEUTICALS - Trademark Details
Status: 686 - Published For Opposition
Serial Number
79310875
Word Mark
MYR PHARMACEUTICALS
Status
686 - Published For Opposition
Status Date
2022-01-18
Filing Date
2020-10-26
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261313, 261321, 261528 - Two quadrilaterals. Quadrilaterals that are completely or partially shaded. Miscellaneous designs with overall polygon shape.
Published for Opposition Date
2022-01-18
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
NEVILLE, JAMES B
Statements
Indication of Colors claimed
The color(s) red, gray, and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Description of Mark
The mark consists of the wording "MYR PHARMACEUTICALS" in gray next to two quadrilaterals in gray and a triangle in red, with the letters "MYR" in white in the triangle.
Goods and Services
Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligopeptides; polypeptides; proteins [raw material]; polynucleotides [chemicals for scientific purposes]; oligonucleotides [chemicals for scientific purposes]; nucleic acids; SiRNA molecules; small molecules having a molar mass of 160 to 480 [for scientific purposes]
Goods and Services
Pharmaceutical preparations for the treatment of liver, viral, and infectious diseases; pharmaceutical preparations for hepatic diseases or disorders; pharmaceutical preparations for hepatitis D
Goods and Services
Scientific, surveying, weighing, measuring apparatus and instruments; apparatus and instruments for scientific research, in particular scientific research in laboratories; data processing apparatus; computers; CDs; DVDs; digital recording media; computer software
Goods and Services
Scientific and technological services and research and design relating thereto; industrial analysis services; industrial research services; scientific research for medical, chemical, biological, veterinary and pharmaceutical purposes; scientific and technological services and research and design related thereto in the field of hepatitis B; scientific and technological services and research and design related thereto in the field of hepatitis D; scientific and technological services and research and design related thereto in the field of dyslipidemia; scientific and technological services and research and design related thereto in the field of nonalcoholic steatohepatitis [NASH]; scientific and technological services and research and design related thereto in the field of primary biliary cholangitis [PBC]; scientific and technological services and research and design related thereto in the field of inflammatory diseases; scientific and technological services and research and design related thereto in the field of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services and research and design related thereto in the field of metabolic diseases; scientific and technological services and research and design related thereto in the field of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; design and development of computer hardware and software; scientific and technological services in the field of preclinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], primary biliary cholangitis [PBC], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services in the field of clinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], primary biliary cholangitis [PBC], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [MVP]
Goods and Services
Providing information in the medical field
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-05-18
Primary Code
005
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-05-18
Primary Code
044
Current Trademark Owners
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Gretchen R. Stroud
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1591282
International Registration Date
2020-10-26
International Publication Date
2021-05-13
International Renewal Date
2030-10-26
Auto Protection Date
2022-11-13
International Status
001 - Request for extension of protection established
International Status Date
2021-05-13
Priority Claimed In
True
Priority Claimed Date
2020-04-27
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2021-05-13 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2021-05-18 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-05-18 | ASSIGNED TO EXAMINER |
| 2021-05-20 | NON-FINAL ACTION WRITTEN |
| 2021-05-21 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2021-05-22 | APPLICATION FILING RECEIPT MAILED |
| 2021-05-24 | REFUSAL PROCESSED BY MPU |
| 2021-05-24 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2021-06-21 | REFUSAL PROCESSED BY IB |
| 2021-07-30 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 2021-10-02 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-11-06 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-11-22 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-11-22 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-11-22 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-11-22 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-11-22 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2021-11-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-11-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-11-24 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-12-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-12-29 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-12-29 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2021-12-29 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2022-01-15 | NOTIFICATION PROCESSED BY IB |
| 2022-01-18 | PUBLISHED FOR OPPOSITION |
| 2022-01-18 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
